PHARMA MAR, S.A. based in Madrid, ES has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-05-23 ✅ Patent 12,384,800 granted on 2025-08-12

US20240166666A1

Chemistry; metallurgy

ANTITUMORAL COMPOUNDS

#2 | 2024-02-08 ✅ Patent 12,433,890 granted on 2025-10-07

US20240041874A1

Human necessities

METHOD OF TREATING SCLC AND MANAGING NEUTROPENIA

#3 | 2024-02-08 ✅ Patent 12,324,806 granted on 2025-06-10

US20240041873A1

Human necessities

METHOD OF TREATING SCLC AND MANAGING HEPATOTOXICITY

#4 | 2023-12-07 ✅ Patent 12,440,490 granted on 2025-10-14

US20230390286A1

Human necessities

METHOD OF TREATING SCLC AND MANAGING THROMBOCYTOPENIA

#5 | 2023-05-25 ✅ Patent 12,630,589 granted on 2026-05-19

US20230159594A1

Chemistry; metallurgy

COMPOUNDS FOR USE IN VIRAL INFECTIONS

#6 | 2023-05-25 ✅ Patent 12,648,986 granted on 2026-06-09

US20230158103A1

Human necessities

PLD FOR USE IN COMBINATION IN THE TREATMENT OF CORONAVIRUS

#7 | 2022-08-04 ✅ Patent 11,713,325 granted on 2023-08-01

US20220242883A1

Chemistry; metallurgy

Antitumoral compounds

#8 | 2022-02-24 ✅ Patent 12,215,100 granted on 2025-02-04

US20220056021A1

Chemistry; metallurgy

Anticancer compounds

#9 | 2021-08-12 ✅ Patent 11,339,180 granted on 2022-05-24

US20210246146A1

Chemistry; metallurgy

Antitumoral compounds

#10 | 2021-03-11 ✅ Patent 11,332,480 granted on 2022-05-17

US20210070775A1

Chemistry; metallurgy

Antitumoral compounds

#11 | 2018-11-01 ✅ Patent 10,442,820 granted on 2019-10-15

US20180312529A1

Chemistry; metallurgy

Antitumoral compounds

#12 | 2018-03-22 ✅ Patent 11,590,129 granted on 2023-02-28

US20180078551A1

Human necessities

Combination therapy with an antitumor alkaloid

#13 | 2016-05-12 ✅ Patent 11,224,663 granted on 2022-01-18

US20160129128A1

Human necessities

Antibody drug conjugates

#14 | 2015-12-03 ✅ Patent 9,827,257 granted on 2017-11-28

US20150342972A1

Human necessities

Antitumoral compounds

#15 | 2013-10-10

US20130266666A1

Human necessities

Combination Therapy with an Antitumor Alkaloid

#16 | 2013-04-16 ✅ Patent 8,420,130 granted on 2013-04-16

US9622433

Pharmaceutical formulation of a didemnin compound

#17 | 2013-03-14 ✅ Patent 9,428,524 granted on 2016-08-30

US20130066067A1

Chemistry; metallurgy

Synthetic process for the manufacture of ecteinascidin compounds

#18 | 2013-02-14 ✅ Patent 8,962,602 granted on 2015-02-24

US20130040921A1

Chemistry; metallurgy

Anticancer steroidal lactones unsaturated in position 7 (8)

#19 | 2012-05-03

US20120107417A1

Human necessities

Effective Antitumor Treatments

#20 | 2012-02-16 ✅ Patent 8,710,264 granted on 2014-04-29

US20120041063A2

Human necessities

Antitumoral compounds

#21 | 2011-09-29

US20110237520A1

Chemistry; metallurgy

Anticancer Compounds

#22 | 2011-08-25 ✅ Patent 8,748,388 granted on 2014-06-10

US20110207674A2

Chemistry; metallurgy

Antitumoral compounds

#23 | 2011-05-05

US20110105409A1

Chemistry; metallurgy

Anticancer Compounds

#24 | 2011-03-31 ✅ Patent 8,435,992 granted on 2013-05-07

US20110076343A1

Human necessities

Multiple myeloma treatments

#25 | 2011-03-24

US20110070232A1

Human necessities

Combination Therapy with an Antitumor Alkaloid

#26 | 2011-02-10 ✅ Patent 9,187,445 granted on 2015-11-17

US20110034549A1

Human necessities

Antitumoral compounds

#27 | 2011-01-20

US20110015135A1

Human necessities

Antitumoral Treatments

#28 | 2011-01-13

US20110009335A1

Human necessities

Anticancer Treatments

#29 | 2010-12-23

US20100323021A1

Human necessities

ANTITUMORAL TREATMENTS

#30 | 2010-11-18 ✅ Patent 8,748,388 granted on 2014-06-10

US20100292163A1

Chemistry; metallurgy

Antitumoral compounds

#31 | 2010-11-04

US20100280108A1

Human necessities

Antitumoral Compounds

#32 | 2010-10-21

US20100267732A1

Chemistry; metallurgy

Prognostic Molecular Markers for ET-743 Treatment

#33 | 2010-09-23

US20100240595A1

Human necessities

Improved Antitumoral Treatments

#34 | 2010-09-09

US20100226919A1

Human necessities

Antitumoral Treatments

#35 | 2010-08-26

US20100216817A1

Chemistry; metallurgy

Antitumoral Tetrahydro-Pyrimidines

#36 | 2010-02-25

US20100048690A2

Chemistry; metallurgy

ANTITUMORAL DIHYDROPYRAN-2-ONE COMPOUNDS

#37 | 2010-02-25

US20100048596A2

Chemistry; metallurgy

Indole Derivatives as Antitumoral Compounds

#38 | 2010-02-18

US20100041594A1

Human necessities

Use of Aplidine for the Treatment of Pancreatic Cancer

#39 | 2010-01-14

US20100009906A1

Human necessities

Anticancer Treatments

#40 | 2009-12-31

US20090324744A1

Human necessities

Effective Antitumor Treatments

#41 | 2009-12-03

US20090298752A1

Human necessities

APLIDINE TREATMENT OF CANCERS

#42 | 2009-10-01 ✅ Patent 8,258,098 granted on 2012-09-04

US20090246168A1

Human necessities

Antitumoral treatments

#43 | 2009-08-06 ✅ Patent 7,772,241 granted on 2010-08-10

US20090197901A1

Chemistry; metallurgy

Variolin derivatives and their use as antitumor agents

#44 | 2009-07-23 ✅ Patent 8,324,406 granted on 2012-12-04

US20090186938A1

Chemistry; metallurgy

Antitumoral dihydropyran-2-one compounds

#45 | 2009-06-25 ✅ Patent 7,795,260 granted on 2010-09-14

US20090163507A1

Chemistry; metallurgy

Synthesis of naturally occurring ecteinascidins and related compounds

#46 | 2009-05-21

US20090130675A1

Chemistry; metallurgy

Genes Involved in the Biosynthesis of Thiocoraline and Heterologous Production of Same

#47 | 2009-05-14

US20090124647A1

Chemistry; metallurgy

Indole Derivatives as Antitumoral Compounds

#48 | 2009-03-24 ✅ Patent 7,507,766 granted on 2009-03-24

US10398835

Treatment of cancers

#49 | 2009-03-19 ✅ Patent 9,192,568 granted on 2015-11-24

US20090076016A1

Human necessities

Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases

#50 | 2009-01-29

US20090030068A1

Chemistry; metallurgy

Antitumour Compounds

#51 | 2009-01-27 ✅ Patent 7,482,429 granted on 2009-01-27

US10182881

Kahalalide F and related compounds

#52 | 2009-01-06 ✅ Patent 7,473,681 granted on 2009-01-06

US10399571

Kahalalide F

#53 | 2008-12-25

US20080318849A1

Chemistry; metallurgy

Kahalalide F and Related Compounds

#54 | 2008-09-25

US20080234363A1

Chemistry; metallurgy

Antitumoral Compounds

#55 | 2008-07-31 ✅ Patent 7,723,068 granted on 2010-05-25

US20080182302A2

Chemistry; metallurgy

Gene cluster involved in safracin biosynthesis and its uses for genetic engineering

#56 | 2008-03-25 ✅ Patent 7,348,310 granted on 2008-03-25

US10312341

Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them

#57 | 2008-02-28 ✅ Patent 8,012,975 granted on 2011-09-06

US20080051407A1

Chemistry; metallurgy

Antitumoral analogs of ET-743

#58 | 2008-02-21 ✅ Patent 7,524,956 granted on 2009-04-28

US20080045713A1

Chemistry; metallurgy

Hemisynthetic method and new compounds

#59 | 2008-02-12 ✅ Patent 7,329,666 granted on 2008-02-12

US10343391

Derivatives of variolin B

#60 | 2007-11-29 ✅ Patent 8,119,638 granted on 2012-02-21

US20070275942A1

Human necessities

Compositions and uses of ET743 for treating cancer

#61 | 2007-07-10 ✅ Patent 7,241,892 granted on 2007-07-10

US9979404

Hemisynthetic method and new compounds

#62 | 2007-04-26 ✅ Patent 7,767,659 granted on 2010-08-03

US20070093658A1

Chemistry; metallurgy

Synthesis of naturally occurring ecteinascidins and related compounds

#63 | 2006-10-19 ✅ Patent 7,495,000 granted on 2009-02-24

US20060235223A1

Chemistry; metallurgy

Variolin derivatives and their use as antitumor agents

#64 | 2006-08-03 ✅ Patent 7,381,703 granted on 2008-06-03

US20060172926A1

Human necessities

Aplidine for multiple myeloma treatment

#65 | 2006-06-15 ✅ Patent 7,763,615 granted on 2010-07-27

US20060128711A1

Chemistry; metallurgy

Ecteinascidin analogs for use as antitumour agents

#66 | 2006-05-25 ✅ Patent 7,420,051 granted on 2008-09-02

US20060111570A1

Chemistry; metallurgy

Synthetic process for the manufacture of an ecteinaschidin compound

#67 | 2006-05-18 ✅ Patent 7,759,345 granted on 2010-07-20

US20060106021A1

Chemistry; metallurgy

Antitumoral derivatives of ET-743

#68 | 2006-01-26 ✅ Patent 7,410,969 granted on 2008-08-12

US20060019960A1

Chemistry; metallurgy

Antitumoral analogs of ET-743

#69 | 2005-10-06 ✅ Patent 7,348,311 granted on 2008-03-25

US20050222015A1

Human necessities

Derivatives of dehydrodidemnin B

#70 | 2005-03-15 ✅ Patent 6,867,334 granted on 2005-03-15

US9971852

Metabolites of ecteinascidin 743 formed by human cytochrome CYP3A4

#71 | 2005-03-08 ✅ Patent 6,864,283 granted on 2005-03-08

US10203918

Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity

#72 | 2005-01-20 ✅ Patent 7,320,981 granted on 2008-01-22

US20050014778A1

Chemistry; metallurgy

Variolin derivatives as anti-cancer agents

#73 | 2005-01-20 ✅ Patent 7,531,506 granted on 2009-05-12

US20050014684A1

Chemistry; metallurgy

Process for producing trunkamide a compounds

Also check out Pharma Mar, S.A.'s (Madrid, Spain) applicant profile with 24 patent applications submitted.

AssigneeID:

9571 ⎘